6 unchanged sentences
4.1 Specimen Stock Certificate (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 10-Q filed on August 5, 2022)
−Removed: 10.1(1)* QuidelOrtho Employee Deferred Compensation Plan
−Removed: 10.2(1) Form of Retention Compensation Agreement for Joseph M.
−Removed: Busky and Michelle A.
−Removed: Hodges (incorporated by reference to Exhibit 10.3 to the Registrant’s Form 10-Q for the quarter ended June 30, 2024 filed on August 1, 2024)
−Removed: 10.3(1)* Form of Retention and Recognition Compensation Agreement for Philip D.
−Removed: 10.4(1)* Employment Offer Letter, dated September 16, 2024, between QuidelOrtho Corporation and Jonathan Siegrist
+Added: 10.1(1) QuidelOrtho Corporation Second Amended and Restated 2018 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Registrant’s Form 8-K filed on May 27, 2025)
31.1* Certification by Principal Executive Officer of QuidelOrtho Corporation pursuant to Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
13 unchanged sentences
Annual Report Annual Report on Form 10-K for the fiscal year ended December 29, 2024
−Removed: AOCI Accumulated other comprehensive loss
+Added: AOCI Accumulated other comprehensive income (loss)
Board Board of Directors
8 unchanged sentences
EPS Loss per share
+Added: ERP Enterprise resource planning
Exchange Act Securities Exchange Act of 1934, as amended
4 unchanged sentences
JPAC Japan and Asia Pacific
+Added: OBBBA One Big Beautiful Bill Act
OCI Other comprehensive income (loss)
+Added: Optimization Plan Multi-year, enterprise-wide cost-reduction, strategic productivity and margin improvement initiatives that the Company launched in the second quarter of 2025
Ortho Ortho Clinical Diagnostics Holdings plc
−Removed: Quarterly Report Quarterly Report on Form 10-Q for the quarter ended March 30, 2025
+Added: Quarterly Report Quarterly Report on Form 10-Q for the quarter ended June 29, 2025
Quidel Quidel Corporation
12 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: May 7, 2025 QUIDELORTHO CORPORATION
+Added: August 5, 2025 QUIDELORTHO CORPORATION
President and Chief Executive Officer
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.